SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-18-000052
Filing Date
2018-05-21
Accepted
2018-05-21 17:15:39
Documents
10
Period of Report
2018-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a8-k2018x05x21.htm 8-K 50347
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS ex312018-05x21.htm EX-3.1 90259
3 FORM OF COMMON STOCK PURCHASE WARRANT FOR FIRST PRIVATE PLACEMENT ex412018-05x21.htm EX-4.1 94438
4 FORM OF COMMON STOCK PURCHASE WARRANT FOR SECOND PRIVATE PLACEMENT ex422018-05x21.htm EX-4.2 93176
5 OPINION OF COOLEY LLP ex512018-05x21.htm EX-5.1 10780
6 SUBSCRIPTION AGREEMENT ex1012018-05x21.htm EX-10.1 295974
7 PLACEMENT AGENCY AGREEMENT ex1022018-05x21.htm EX-10.2 102835
8 PRESS RELEASE ex9912018-05x21.htm EX-99.1 16657
9 cdtxlogo.jpg GRAPHIC 63449
10 cooleylogo.jpg GRAPHIC 38052
  Complete submission text file 0001610618-18-000052.txt   893995
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 18850521
SIC: 2836 Biological Products, (No Diagnostic Substances)